Respiratory

Latest News

Nerandomilast is an investigational oral, preferential inhibitor of phosphodiesterase 4B that has shown promise in IPF and PPF. | Image credit: Елена Бутусова - stock.adobe.com
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

February 13th 2025

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.

Sanofi | Image credit: Eagle - stock.adobe.com
Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

December 16th 2024

Group of diverse kids | Image Credit: © EKKAPON-stock.adobe.com
Ambient Toxins Linked to Disabilities in Minority Schoolchildren

December 10th 2024

RSV vaccine | Image credit: Pawel - atock.adobe.com
Nirsevimab Protected Infants, Children From Severe RSV in 2023–2024 Season

December 6th 2024

Doctor with an image of lungs | Image credit: lungs_PRASANNAPIX
Key Flu and RSV Recommendations for the 2024-2025 Respiratory Virus Season

November 26th 2024

Continuing Medical Education
View All
April 25th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

What We're Reading
January 5th 2022

What We’re Reading: US Increases Pfizer Pill Order; California At-Home STI Tests; Supreme Court Hearing on Vaccine Mandates

AJMC Staff
The Biden administration doubled its order of Pfizer’s COVID-19 antiviral drug; California is now the first state to require health insurance plans to cover at-home STI tests; the Supreme Court will hear in-person arguments Friday to decide whether to block federal vaccine mandates.
Top 5 Respiratory Articles of 2021
December 29th 2021

Top 5 Respiratory Content of 2021

Hayden E. Klein
An 8-year journey to a chronic cough diagnosis, neurogenic cough treatment, e-cigarettes, and COVID-19 risk factors were among the most-viewed respiratory articles.
Laurie Slovarp, PhD
December 26th 2021

Dr Laurie Slovarp on the Importance of Early Behavioral Cough Therapy

Laura Joszt, MA
Behavioral cough therapy should be used as early intervention, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Timothy C.Pigg, president and CEO, Rotech Healthcare Inc
December 23rd 2021

Contributor: Objective Documentation Protects Patient Access to Home Oxygen Therapy

Timothy C. Pigg
Facing the challenges created by the COVID-19 pandemic, the US medical community has been forced to rapidly change and modernize the manner in which it delivers health care over the last year-and-a-half. 
A Timeline of COVID-19 Vaccine Developments for the Second Half of 2021
December 23rd 2021

A Timeline of COVID-19 Vaccine Developments for the Second Half of 2021

AJMC Staff
Although 2021 closes with a plentiful supply of COVID-19 vaccines and boosters, Americans continue to face challenges with the widespread Omicron variant and new testing hurdles.
Laurie Slovarp, PhD
December 19th 2021

Dr Laurie Slovarp on Preventing and Suppressing Chronic Cough Events

Laura Joszt, MA
Most people are aware of what triggers their chronic cough and how to temporarily suppress it, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
FDA Approves Tezepelumab for Severe Asthma
December 17th 2021

FDA Approves Tezepelumab for Severe Asthma

Allison Inserro
Laurie Slovarp, PhD
December 12th 2021

Dr Laurie Slovarp Explains How Chronic Cough Impacts Quality of Life

Laura Joszt, MA
Chronic cough can be very debilitating to a patient's quality of life, explained Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Woman using inhaler
December 10th 2021

Asthma Education Linked to Better 1-Year Disease Control Outcomes in Adolescents, Study Finds

Hayden E. Klein
Participation in education sessions and frequent web-based monitoring predicted 1-year outcomes of asthma control for adolescents with partly controlled and uncontrolled asthma.
Peter Dicpinigaitis, MD
December 6th 2021

COVID-19 Not Creating Lingering Chronic Cough Impacts, Dr Peter Dicpinigaitis Says

Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center, discusses what he and others have seen during the pandemic in patients with chronic cough who had COVID-19.
Electrical treatment
December 3rd 2021

TENS Has Potential as a Treatment for Chronic Cough, Small Study Finds

Hayden E. Klein
A small study found that patients with chronic cough saw improvements in symptoms following transcutaneous electrical nerve stimulation treatment, with minimal adverse effects.
Doctor with patient
December 2nd 2021

FeNO Values Linked to ICS Therapy Response Rates in Patients With Chronic Cough

Hayden E. Klein
A systematic review showed that a high fractional exhaled nitric oxide (FeNO) value before starting inhaled corticosteroid (ICS) therapy may be associated with higher response rates in patients with chronic cough.
lung graphic
November 27th 2021

Potential Markers of COVID-19 Severity Found Among Patients With Chronic Airway Diseases

Gianna Melillo
Results of a retrospective study revealed potential markers of COVID-19 severity among those with chronic obstructive pulmonary disease, asthma, or chronic bronchitis.
Woman with heartburn
November 24th 2021

Heartburn Can Predict Acid Suppression Success in Chronic Cough, Study Finds

Hayden E. Klein
Despite a relatively low response rate to acid suppression therapy to treat chronic cough, heartburn was a highly significant predictor of success.
Nurse with patient in nursing home
November 20th 2021

Poor Nutritional Status May Predict High Pneumonia Risk in Elderly, Study Finds

Hayden E. Klein
The prognosis was worse in patients with basic dementia or Alzheimers disease as well as chronic obstructive pulmonary disease or asthma.
Doctor treating man with inhaler
November 19th 2021

Bronchial Hyperresponsiveness May Predict Cough-Variant Asthma in Adults With Chronic Cough

Hayden E. Klein
The study found that cough severity and cough-related quality of life were not related to the severity of bronchial hyperresponsiveness in nonsmoking adults with cough-variant asthma.
Ron Eccles MD
November 9th 2021

Dr Ron Eccles on Measuring the Blinding That Happens in Chronic Cough Therapy Trials

Most adverse events in trials of adenosine triphosphate (ATP) blockers for chronic cough are related to taste, which may inadvertently cause the studies to become unblinded to patients, and a way of measuring this to know the extent of the problem is needed, said Ron Eccles, BSc, PhD, DSc, emeritus professor at Cardiff University.
Site Logo
November 8th 2021

Evaluation of a Pediatric Asthma High-risk Scoring Algorithm

Harold J. Farber, MD, MSPH Edwin A. Silveira, BS Robert Moore, MD Marianna M. Sockrider, MD, DrPH
An asthma risk score using 7 clinically relevant parameters evaluated in a pediatric Medicaid managed care population can stratify risk for following-year asthma hospitalization.
Teen girl using vape product
October 29th 2021

Adolescent Cannabis Vaping Doubled in 7 Years in US, Canada, Review Finds

Hayden E. Klein
Multiple nationally representative surveys found that approximately 1 in 3 grade 12 students vaped cannabis in 2018 alone.
WWR banner
October 28th 2021

What We’re Reading: Medicare Readmission Penalties; Cigarette Sales Rose in 2020; Antidepressant Shows Promise as COVID-19 Treatment

AJMC Staff
Medicare punished more than 2000 hospitals for high readmissions; cigarette sales increased in 2020 for the first time in 2 decades; a cheap antidepressant showed promise as an affordable oral treatment for COVID-19.
Dr Peter Dicpinigaitis
October 22nd 2021

Dr Peter Dicpinigaitis on Gender, Ethnic Differences in Chronic Cough

Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine, director of the Montefiore Cough Center, and editor-in-chief of LUNG, addresses gender and chronic cough
US Cigarette Sales 14% Higher Than Expected During Pandemic, Report Finds
October 20th 2021

US Cigarette Sales 14% Higher Than Expected During Pandemic, Report Finds

Hayden E. Klein
While sales have gone up, the research does not directly show whether there is an increase in people smoking cigarettes.
Site Logo
October 13th 2021

Medicare Advantage–Pharmacy Partnership Improves Influenza and Pneumococcal Vaccination Rates

Richard L. Sheer, BA David P. Nau, PhD Nicholas Dorich, PharmD Jesse McCullough, PharmD Annette D. Boyer, RPh Matthew Pickering, PharmD Patrick J. Campbell, PharmD, PhD Margaret K. Pasquale, PhD
Patients whose pharmacy receives notification of their immunization gap have twice the odds of receiving immunizations compared with those whose pharmacy does not receive the notification.
Paulette Nyahay
October 10th 2021

Paulette Nyahay on the Empowerment That Comes From Talking About Chronic Cough

Paulette Nyahay has a chronic cough unrelated to her asthma; here, she discusses how she works with multiple doctors and about how she discusses her condition with others.
newspaper stack
October 8th 2021

What We’re Reading: Fall in US COVID-19 Deaths; Permissible Air Pollution Levels Increase Mortality Risk; Moderna Production Challenges

AJMC Staff
New data show a decrease in COVID-19 deaths in the United States; long-term exposure to low levels of air pollution increases mortality risk; Moderna pressured to ramp up vaccine production.
Inflamed bronchi
October 8th 2021

Cough-Variant Asthma Linked to Bronchial Sensitivity in Nonsmokers

Emily Brill
Bronchial hyperresponsiveness may indicate the presence of cough-variant asthma in nonsmokers who have chronic cough, new research shows.
Peter Dicpinigaitis, MD
October 5th 2021

Dr Peter Dicpinigaitis Discusses the State of Chronic Cough Treatment

Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine, director of the Montefiore Cough Center, and editor-in-chief of LUNG, addresses the lack of approved treatments for chronic cough in the United States, current off-label remedies, and the prospect of future approvals.
Dr Ron Eccles on Therapies That Block ATP and Reduce Cough
September 29th 2021

Dr Ron Eccles on Therapies That Block ATP and Reduce Cough

Therapies that block adenosine triphosphate (ATP) can reduce the irritation that causes cough, and some currently being studied also don’t have taste side effects that can confound clinical trial results, explained Ron Eccles, BSc, PhD, DSc, emeritus profess at Cardiff University.
health graphic
September 24th 2021

Study: CST Effective in Patients With Concurrent CRC, Voice Disorders

Gianna Melillo
Analysis results highlight the efficacy of cough suppression therapy (CST) for those with chronic refractory cough and voice disorders.
COVID-19 Symptoms Can Differentiate Respiratory Diseases, Study Says
September 21st 2021

COVID-19 Symptoms Can Differentiate Respiratory Diseases, Study Says

Hayden E. Klein
Among patients with COVID-19, chronic obstructive pulmonary disease and asthma were more prevalent than allergic rhinitis.
<1
...
34567891011
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo